跳至主要内容
临床试验/NL-OMON46590
NL-OMON46590招募中不适用

Rate of progression in USH2A related retinal degeneration - RUSH2A

Jaeb Center For Health Research0 个研究点目标入组 25 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
2 至 99(—)

入选标准

  • 2.2.1 Study Participant Inclusion Criteria
  • 1. Willing and able to complete the informed consent process
  • 2. Ability to return for all study visits over 48 months if in the natural history study
  • 3. Age * 8 years
  • 4. At least 2 pathogenic or likely pathogenic mutations in USH2A gene from a clinically certified lab report

排除标准

  • 2.2.2 Study Participant Exclusion Criteria
  • 1. Mutations in genes that cause autosomal dominant RP, X-linked RP, or presence of biallelic mutations in autosomal recessive RP/retinal dystrophy genes other than USH2A
  • 2. Expected to enter experimental treatment trial at any time during this study
  • 3. History of more than 1 year of cumulative treatment, at any time, with an agent associated with pigmentary retinopathy (including hydroxychloroquine, chloroquine, thioridazine, and deferoxamine)

研究者

发起方
Jaeb Center For Health Research

相似试验

Rate of progression in USH2A related retinal... | 临床试验